New drug aimed at taming Immunotherapy's stubborn side effects
Symptom relief
Terminated
This study was designed to see if the drug itacitinib can help people whose immune system overreacts to cancer immunotherapy, causing side effects that steroids can't fix. It was planned for adults with certain cancers who had these stubborn side effects. However, the study was w…
Phase: PHASE2 • Sponsor: Douglas Johnson • Aim: Symptom relief
Last updated May 04, 2026 16:21 UTC